FUT10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.557800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.309400E-01
Normal-vs-Stage2
9.142800E-01
Normal-vs-Stage3
7.567400E-01
Normal-vs-Stage4
4.644600E-01
Stage1-vs-Stage2
9.850800E-01
Stage1-vs-Stage3
8.646000E-01
Stage1-vs-Stage4
3.659000E-01
Stage2-vs-Stage3
8.621000E-01
Stage2-vs-Stage4
2.076200E-01
Stage3-vs-Stage4
3.023200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.945600E-01
Normal-vs-AfricanAmerican
4.122600E-01
Normal-vs-Asian
9.679800E-01
Caucasian-vs-AfricanAmerican
8.928000E-02
Caucasian-vs-Asian
5.655400E-01
AfricanAmerican-vs-Asian
3.897800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.859000E-01
Normal-vs-Female
9.349800E-01
Male-vs-Female
4.595400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.300400E-01
Normal-vs-Age(41-60Yrs)
9.270600E-01
Normal-vs-Age(61-80Yrs)
8.058800E-01
Normal-vs-Age(81-100Yrs)
4.186800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.078400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.144800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.001400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.328600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.298360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.913000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.632600E-01
Normal-vs-Daily Drinker
2.119800E-01
Normal-vs-Weekly Drinker
8.688000E-01
Normal-vs-Occasional Drinker
9.093000E-01
Normal-vs-Social Drinker
9.274400E-01
Non Drinker-vs-Daily Drinker
7.372100E-02
Non Drinker-vs-Weekly Drinker
4.699200E-01
Non Drinker-vs-Occasional Drinker
7.530600E-01
Non Drinker-vs-Social Drinker
4.511400E-01
Daily Drinker-vs-Weekly Drinker
8.850100E-02
Daily Drinker-vs-Occasional Drinker
7.284400E-02
Daily Drinker-vs-Social Drinker
1.470310E-02
Weekly Drinker-vs-Occasional Drinker
6.238400E-01
Weekly Drinker-vs-Social Drinker
8.095200E-01
Occasional Drinker-vs-Social Drinker
7.242000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.382400E-02
Normal-vs-Grade 2
1.544430E-02
Normal-vs-Grade 3
1.286310E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.704300E-03
Grade 1-vs-Grade 3
1.755810E-02
Grade 1-vs-Grade 4
5.382400E-02
Grade 2-vs-Grade 3
8.189400E-01
Grade 2-vs-Grade 4
1.544430E-02
Grade 3-vs-Grade 4
1.286310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.841800E-01
Normal-vs-NonDiabetic
7.553800E-01
Diabetic-vs-NonDiabetic
5.754800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.595800E-01
Normal-vs-NoPancreatitis
7.547000E-01
Pancreatitis-vs-NoPancreatitis
8.077600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.679400E-01
Normal-vs-N1
9.212600E-01
N0-vs-N1
4.938400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.129200E-01
Normal-vs-TP53-NonMutant
9.558600E-01
TP53-Mutant-vs-TP53-NonMutant
8.816200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
